Abbas Motazedi, MD
1160 Varnum St Ne Ste 111, Washington, DC 20017
Source: CMS National Provider Identifier registry Source: CMS NPI registry Data updated July 2026
72 NPI‑verified weight loss and GLP‑1 providers across 2 District of Columbia cities — every listing sourced from the federal provider registry.
District of Columbia has 72 providers registered with the federal government under an obesity medicine, bariatric medicine, or endocrinology specialty, spread across 2 cities. Washington has the most, with 71. Registry listing confirms a provider's specialty, not that they currently prescribe semaglutide or tirzepatide.
Shown in source-data order. We do not rank, rate, or feature providers — pick a city above to see every listing in your area.
1160 Varnum St Ne Ste 111, Washington, DC 20017
1712 I St Nw, Washington, DC 20006
3 Washington Cir Nw Ste 303, Washington, DC 20037
1120 19th St Nw, Washington, DC 20036
1200 G St Nw Ste 800, Washington, DC 20005
106 Irving St Nw, Washington, DC 20010
The CMS NPI registry lists 72 weight loss, obesity medicine, bariatric, and endocrinology providers in District of Columbia, across 2 cities. Washington has the most, with 71 listed providers.
Yes. Telehealth GLP-1 treatment is available to District of Columbia residents. An online visit with a licensed provider can result in a prescription for semaglutide or tirzepatide when medically appropriate, with medication shipped to your door.
Most clinics evaluate patients for semaglutide and tirzepatide. Availability, pricing, and whether a clinic dispenses an FDA-approved brand-name product or a compounded preparation all vary by practice. Compounded drugs are prepared by a state-licensed compounding pharmacy; they are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality. Call ahead to confirm what a practice offers.